359 related articles for article (PubMed ID: 19366271)
21. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
Melian EB; Jarvis B
Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
Rhee MY; Baek SH; Kim W; Park CG; Park SW; Oh BH; Kim SH; Kim JJ; Shin JH; Yoo BS; Rim SJ; Ha JW; Doh JH; Ahn Y; Chae JK; Park JB; Kim SK; Kim CH
Drug Des Devel Ther; 2015; 9():2847-54. PubMed ID: 26082615
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
Malmqvist K; Kahan T; Dahl M
Am J Hypertens; 2000 May; 13(5 Pt 1):504-11. PubMed ID: 10826401
[TBL] [Abstract][Full Text] [Related]
24. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
25. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
[TBL] [Abstract][Full Text] [Related]
26. Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy.
Bönner G;
Blood Press Suppl; 2008 Dec; 2():22-30. PubMed ID: 19203019
[TBL] [Abstract][Full Text] [Related]
27. Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.
Mengden T; Uen S; Bramlage P
Vasc Health Risk Manag; 2009; 5():1043-58. PubMed ID: 20057897
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial.
Association of Black Cardiologists (ABC) Candesartan Study Group
Heart Dis; 2000; 2(6):392-9. PubMed ID: 11728289
[TBL] [Abstract][Full Text] [Related]
30. Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.
Bramlage P; Buhck H; Zemmrich C
Clin Drug Investig; 2014 Apr; 34(4):241-9. PubMed ID: 24482018
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
[TBL] [Abstract][Full Text] [Related]
32. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
33. Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients.
Mancia G; Omboni S;
Blood Press Suppl; 2004 Dec; 2():11-7. PubMed ID: 15631278
[TBL] [Abstract][Full Text] [Related]
34. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
35. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
Lewin AJ; Weir MR
Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
[TBL] [Abstract][Full Text] [Related]
37. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
Karlson BW; Zetterstrand S; Olofsson B; Elmfeldt D
Blood Press; 2009; 18(3):149-56. PubMed ID: 19462314
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
39. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.
Sellin L; Stegbauer J; Laeis P; Rump LC
J Hypertens; 2005 Nov; 23(11):2083-92. PubMed ID: 16208152
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
